Multifaceted Topical

Article

Pittsburgh -Topical tacrolimus ointment 0.1 percent (Protopic) may be a viable addition to the current therapeutic armamentarium for early-stage cutaneous T-cell lymphoma (CTCL), Larisa Geskin, M.D., said.

Related Videos
Related Content

DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

85% of Survey Respondents Do Not Know What Actinic Keratosis Is

September 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Understanding the Impact of Prurigo Nodularis Itch, Sleep Loss, and Quality of Life

September 28th 2023

2023 Dermatology Research to Ponder

September 28th 2023

DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

85% of Survey Respondents Do Not Know What Actinic Keratosis Is

September 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Understanding the Impact of Prurigo Nodularis Itch, Sleep Loss, and Quality of Life

September 28th 2023

2023 Dermatology Research to Ponder

September 28th 2023

DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day

September 29th 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

85% of Survey Respondents Do Not Know What Actinic Keratosis Is

September 28th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Understanding the Impact of Prurigo Nodularis Itch, Sleep Loss, and Quality of Life

September 28th 2023

2023 Dermatology Research to Ponder

September 28th 2023
© 2023 MJH Life Sciences

All rights reserved.